Ingersoll, Matthew A <br/><br/>
Statin derivatives as therapeutic agents for castration-resistant prostate cancer.  [electronic resource] 

 -  Cancer letters  12 2016 
 - 94-105 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2016.09.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--pharmacology<br/>Antineoplastic Agents, Hormonal--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cholesterol--metabolism<br/>Docetaxel<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Male<br/>Neoplasm Invasiveness<br/>Prostatic Neoplasms, Castration-Resistant--drug therapy<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Receptors, Androgen--drug effects<br/>S Phase Cell Cycle Checkpoints--drug effects<br/>Signal Transduction--drug effects<br/>Simvastatin--analogs & derivatives<br/>Taxoids--pharmacology